A Comparative Study of the Efficacy and Safety of Procainamide Versus Propafenone Versus Amiodarone for the Conversion of Recent-Onset Atrial Fibrillation

American Journal of Cardiology

Volumn 99, Issue 12, 2007, Pages 1721-1725

  Kochiadakis, George E ^a   Igoumenidis, Nikos E ^a   Hamilos, Michail E ^a   Marketou, Maria E ^a   Chlouverakis, Gregory I ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; PLACEBO; PROCAINAMIDE; PROPAFENONE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INJECTION SITE PHLEBITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE; TORSADE DES POINTES;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROCAINAMIDE; PROPAFENONE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 34250021357     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.059     Document Type: Article

References (15)

1. Pritchett E.L. Management of atrial fibrillation. N Engl J Med 326 (1992) 1264-1271
2. Prystowsky E.N., Benson Jr. D.W., Fuster V., Hart R.G., Kay G.N., Myerburg R.J., Naccarelli G.V., and Wyse D.G. Management of patients with atrial fibrillation. A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association. Circulation 93 (1996) 1262-1277
3. Jung F., and DiMarco J.P. Treatment strategies for atrial fibrillation. Am J Med 104 (1998) 272-286
4. Costeas C., Kassotis J., Blitzer M., and Reiffel J.A. Rhythm management in atrial fibrillation-with a primary emphasis on pharmacological therapy: part 2. Pacing Clin Electrophysiol 21 (1998) 742-752
5. Naccarelli G.V., Wolbrette D.L., Khan M., Bhatta L., Hynes J., Samii S., and Luck J. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 91 suppl (2003) 15D-26D
6. Khan I.A., Mehta N.J., and Gowda R.M. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol 89 (2003) 239-248
7. Snow V., Weiss K.B., LeFevre M., McNamara R., Bass E., Green L.A., Michl K., Owens D.K., Susman J., Allen D.I., and Mottur-Pilson C. AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 139 (2003) 1009-1017
8. Reiffel J.A. Drug choices in the treatment of atrial fibrillation. Am J Cardiol 85 suppl (2000) 12D-19D
9. Blanc J.J., Voinov C., Maarek M., and PARSIFAL Study Group. Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. Am J Cardiol 84 (1999) 1029-1032
10. Chevalier P., Durand-Dubief A., Burri H., Cucherat M., Kirkorian G., and Touboul P. Amiodarone versus placebo and classic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 41 (2003) 255-262
11. Mitchell L.B., Wyse D.G., Gillis A.M., and Duff H.J. Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects. Circulation 80 (1989) 34-42
12. Wang J., Bourne G.W., Wang Z., Villemaire C., Talajic M., and Nattel S. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: importance of use-dependent effects on refractoriness. Circulation 88 (1993) 1030-1044
13. Fenster P.E., Comess K.A., Marsh R., Katzenberg C., and Hager W.D. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 106 (1983) 501-504
14. Falk R.H., Knowlton A.A., Bernard S.A., Gotlieb N.E., and Battinelli N.J. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med 106 (1987) 503-506
15. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Levy S., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 104 (2001) 2118-2150